This study demonstrated, that the PDE4 inhibitor roflumilast and the PDE3/PDE4 inhibitor pumafentrine dose-dependently ameliorated the clinical score and colonic TNFα production in murine DSS-induced colitis in a preventive setting, while not affecting the histopathologic colonic findings. The gene discussed is PDE4A; the disease is colitis.